10.0 Abstract: Imaging Shared Service The mission of the Imaging Shared Service (ISS) is to provide a wide array of state-of-the-art imaging services that permit structural and functional imaging of cells, whole animals, and humans. Major goals include offering UMGCC investigators access to a wide range of imaging modalities and instrumentation; providing onsite expertise to aid experimental design, execution, data processing, and data analysis; and providing an environment that fosters collaboration and innovation and encourages clinically relevant studies. An additional important goal is UMGCC investigator training, as the ISS is committed to broadening the knowledge of the institutional faculty, staff, fellows, and students regarding state-of-the-art imaging technology. The ISS is a new UMGCC shared service that permits studies ranging from cells to mouse to whole body clinical imaging. Because of demand for these services, the ISS has grown rapidly in a short period of time. Moreover, the translational research component of the ISS has increased significantly, with more users focused on translating discoveries to the clinic. In 2014, the ISS supported 79 Cancer Center members, 43 percent of whom have peer-reviewed funding. ISS users (31 percent of all UMGCC members) spanned all 5 research programs. The ISS supports many cancer- related publications annually, many in high-impact journals including Cancer Research and JAMA.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA134274-13
Application #
9984994
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
2008-08-08
Project End
2021-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
13
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Type
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Wang, Junxiang; Zhao, Liang; Ye, Yanfang et al. (2018) Adverse event detection by integrating twitter data and VAERS. J Biomed Semantics 9:19
Furusawa, Aki; Reiser, John; Sadashivaiah, Kavitha et al. (2018) Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy. J Immunother 41:53-63
Nathenson, Michael J; Conley, Anthony P; Sausville, Edward (2018) Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas. Oncologist 23:71-83
Wang, Lei; Felts, Sara J; Van Keulen, Virginia P et al. (2018) Exploring the effect of library preparation on RNA sequencing experiments. Genomics :
Nathenson, Michael J; Barysauskas, Constance M; Nathenson, Robert A et al. (2018) Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma. World J Surg Oncol 16:203
Sallmyr, Annahita; Tomkinson, Alan E (2018) Repair of DNA double-strand breaks by mammalian alternative end-joining pathways. J Biol Chem 293:10536-10546
Kerr, Candace; Adhikary, Gautam; Grun, Daniel et al. (2018) Combination cisplatin and sulforaphane treatment reduces proliferation, invasion, and tumor formation in epidermal squamous cell carcinoma. Mol Carcinog 57:3-11
Connolly, Sean; Quasi-Woode, Devona; Waldron, Laura et al. (2018) Calcineurin Regulatory Subunit Calcium-Binding Domains Differentially Contribute to Calcineurin Signaling in Saccharomyces cerevisiae. Genetics 209:801-813
Pauza, C David; Liou, Mei-Ling; Lahusen, Tyler et al. (2018) Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local. Front Immunol 9:1305
Wang, Lei; Felts, Sara J; Van Keulen, Virginia P et al. (2018) Integrative Genome-Wide Analysis of Long Noncoding RNAs in Diverse Immune Cell Types of Melanoma Patients. Cancer Res 78:4411-4423

Showing the most recent 10 out of 257 publications